Navigation Links
Studying illnesses caused by worms: Scientists are learning how immune cells communicate
Date:10/8/2010

Saranac Lake, N.Y. A billion people living in underdeveloped areas around the world are infected with parasitic helminthes, worms that survive by residing in and feeding on their hosts. These infestations can cause chronic intestinal (and occasionally systemic) illnesses leading to long-term disability. Irah King and Markus Mohrs, biomedical researchers at the Trudeau Institute, are investigating illnesses caused by these gut-dwelling worms in an effort to decipher how immune cells send and receive signals that determine the specific immune response to mount.

In a study reported in the current issue of the Journal of Immunology, Dr. King and his colleagues demonstrate that a soluble factor released by CD4+ T cells (a subset of cells that aid B cells in generating an immune response) called interleukin-21 (IL-21) instructs B cells to produce antibodies that bind helminth-derived products and inhibit their ability to mature into adult worms in the host.

Using genetically modified mice that lack the receptor for IL-21, they found that B cells directly require IL-21 signals in order to differentiate into plasma cells, the major antibody-producing B cell subset. The role of IL-21 signaling in this context seems to be specific because it does not impact other forms of B cell activation or CD4+ T cell differentiation, another leukocyte subset critical for protective immunity to helminthes.

"It is already established that B cells must produce antibodies to protect us from gut-dwelling worms and other parasitic infections," said Dr. King. "However, the signals that B cells need to receive in order to produce antibodies following infection are not yet completely understood."

Scientists who study anti-parasite immunity understand that immune responses generated by worm infections are in many ways similar to responses generated by diseases more common in the developed world like asthma, allergies, and ulcerative colitis. By identifying these similarities, Dr. King and other researchers hope to point to new treatments and therapies for a host of diseases associated with problems in immune system regulation.


'/>"/>

Contact: Brian Turner
bturner@trudeauinstitute.org
518-891-3080
Trudeau Institute
Source:Eurekalert

Related biology news :

1. Carnegie Mellon receives funding to create new program studying environmental impact of nanotechnology
2. New retrieval method makes studying cancer proteins easier
3. Introducing Robofish: Leading the crowd in studying group dynamics
4. Studying cells in 3-D could reveal new cancer targets
5. New lab manual for studying the biology of the nervous system in Drosophila is released
6. Studying hair of ancient Peruvians answers questions about stress
7. Exploration by explosion: Studying the inner realm of living cells
8. Model microbial community for studying expanding dead zones characterized
9. Geologists studying groundwater arsenic levels in India empower Bengali women, children
10. K-State receives more than $780,000 to fund graduate students studying ecology, evolution, genomics
11. LSU receives $3.6 million to fund center studying hazardous waste cleanup and health impacts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/15/2016)... Jan. 15, 2016 Recent publicized breaches in ... find new ways to ensure data security and user ... and Android that ties a user,s ... it into a hardware authorization token. Customer service agents ... fingerprint on their KodeKey enabled device to verify their ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the ... nearly 10,000 retail locations, web and mobile, today ... $40 million from existing investors. ... be devoted to further innovate higi,s health platform ... and web portal – including expanding services and ...
Breaking Biology News(10 mins):
(Date:2/3/2016)...  Discovery Laboratories, Inc. (NASDAQ: DSCO ), ... surfactant therapies for respiratory diseases, today announced that ... award as a component of employment compensation for ... and Chief Executive Officer.  The award was approved ... 2016 and granted as an inducement material to ...
(Date:2/3/2016)... Feb. 3, 2016 Harvard Apparatus Regenerative ... company developing bioengineered organ implants for life-threatening conditions ... that CEO Jim McGorry , will present ... on Tuesday, February 9, 2016 at 8:00 ... . HART,s presentation will be webcast live ...
(Date:2/3/2016)... ON (PRWEB) , ... February 03, 2016 , ... ... and validating a series of potential targets (epitopes) specific to misfolded, propagating strains ... targets to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from ...
(Date:2/3/2016)... Feb. 3, 2016  Silk Therapeutics, Inc., today announced the ... Therapeutics has now raised a total of $10.25 million in ... company. The Series A2 round was led by existing investor ... with participation from new investors Lear Corporation and Highland Consumer ... P. Disney ; Richard Sackler , MD, with Summer ...
Breaking Biology Technology: